Wikidata

(Q61980536)

English

A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
TIMER (English)
0 references
title
A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients "TIMER" Study (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Belgium
0 references
Mexico
0 references
Poland
0 references
Romania
0 references
Saudi Arabia
0 references
Ukraine
0 references
start time
August 2009
0 references
end time
July 2012
0 references
number of participants
224
0 references
minimum age
18 year
0 references
maximum age
60 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61980536&oldid=2149179675"